Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2006-05-16 16:00 2006-05-12 UFPT UFP TECHNOLOGIES INC BAILLY R JEFFREY Director, Officer, 10% owner SELL $6.00 10,000 $60,000 464,356
2006-05-16 00:23 2006-05-11 UFPT UFP TECHNOLOGIES INC CURRY WILLIAM C Director OPT+S $5.97 19,600 $116,975 16,752
2006-05-12 16:27 2006-05-11 UFPT UFP TECHNOLOGIES INC SHAW WILLIAM Director, Officer, 10% owner SELL $6.02 20,000 $120,428 342,924
2006-05-12 20:44 2006-05-10 CRY Artivion Inc. ANDERSON STEVEN G Director, Officer SELL $4.84 25,000 $121,095 1,193,760
2006-05-13 01:01 2005-11-02 OFIX Orthofix Medical Inc. MILINAZZO ALAN Officer BUY $37.78 200 $7,556 200
2006-05-12 22:23 2006-05-11 UFPT UFP TECHNOLOGIES INC WORRELL PETER R Director, 10% owner SELL $6.04 48,000 $289,795 315,000
2006-05-13 02:03 2006-05-10 CYTX PLUS THERAPEUTICS, INC. CALHOUN CHRISTOPHER J Officer OPT+S $8.06 11,960 $96,400 150,000
2006-05-12 23:34 2006-05-11 UFPT UFP TECHNOLOGIES INC BAILLY R JEFFREY Director, Officer, 10% owner SELL $6.00 10,100 $60,600 474,356
2006-05-11 16:48 2006-05-10 DCTH DELCATH SYSTEMS, INC. LADD ROBERT 10% owner BUY $5.73 23,548 $134,890 2,009,839
2006-05-11 18:52 2006-05-10 N-A BOSTON SCIENTIFIC CORP NICHOLAS NICHOLAS J JR Director BUY $21.39 10,000 $213,900 40,000
2006-05-11 18:52 2006-05-10 N-A BOSTON SCIENTIFIC CORP MARIO ERNEST Director BUY $21.35 50,000 $1,067,375 50,000
2006-05-11 17:54 2006-05-10 HAPNU InfuSystem Holdings, Inc Fir Tree, L.L.C. 10% owner SELL $6.05 240,000 $1,452,000 1,822,500
2006-05-11 00:25 2006-05-08 RMD RESMED INC PENDARVIS DAVID Officer OPT+S $47.51 11,015 $523,348 3,442
2006-05-10 01:57 2006-05-08 RMD RESMED INC Gallahue Kieran Officer OPT+S $47.54 50,000 $2,376,800 2,658
2006-05-10 01:23 2006-05-08 RMD RESMED INC EISEN PAUL Officer OPT+S $47.70 10,850 $517,508 0
2006-05-09 15:49 2006-05-05 MMM 3M CO STAKE JAMES B Officer OPT+S $86.98 3,500 $304,430 23,033
2006-05-10 00:20 2006-05-08 MMM 3M CO YEOMANS JAN L Officer SELL $87.44 5,000 $437,200 67,446
2006-05-10 00:58 2006-05-08 RMD RESMED INC FARRELL PETER C Director, Officer SELL $47.70 60,000 $2,862,156 1,101,829
2006-05-09 21:14 2006-05-08 N-A WEST PHARMACEUTICAL SERVICES INC ELLERS STEVEN A Officer OPT+S $36.89 5,000 $184,455 99,683
2006-05-09 17:56 2006-05-05 N-A WEST PHARMACEUTICAL SERVICES INC ANDERSON MICHAEL A Officer OPT+S $37.50 16,000 $599,923 24,707
2006-05-08 16:31 2006-05-04 MMM 3M CO MAHAN JAMES T Officer OPT+S $86.48 5,000 $432,382 16,655
2006-05-08 17:25 2006-05-04 N-A BOSTON SCIENTIFIC CORP DEPARLE NANCY ANN Director SELL $21.91 2,553 $55,936 0
2006-05-09 02:02 2006-05-04 CYTX PLUS THERAPEUTICS, INC. CALHOUN CHRISTOPHER J Officer OPT+S $8.06 6,340 $51,100 50,000
2006-05-05 02:50 2006-05-02 DXCM DEXCOM INC LUCAS DONALD L Director SELL $24.00 50,000 $1,200,000 70,663
2006-05-05 02:37 2006-05-02 DXCM DEXCOM INC Brister Mark Officer SELL $24.00 50,000 $1,200,000 10,967
2006-05-05 02:36 2006-05-02 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $24.00 100,000 $2,400,000 876
2006-05-05 02:36 2006-05-02 DXCM DEXCOM INC Kemper Steven J Officer SELL $24.00 75,000 $1,800,000 25,696
2006-05-05 02:35 2006-05-02 DXCM DEXCOM INC Brauker James H Officer SELL $24.00 82,500 $1,980,000 15,950
2006-05-05 02:35 2006-05-02 DXCM DEXCOM INC Rasdal Andrew P Officer OPT+S $24.00 125,000 $3,000,000 2,944
2006-05-03 15:46 2006-05-01 ANGO Angiodynamics Inc. GERARDI JOSEPH G Officer OPT+S $29.84 4,500 $134,280 242
2006-05-03 15:46 2006-04-24 ANGO Angiodynamics Inc. HOBBS EAMONN P Director, Officer OPT+S $29.73 34,000 $1,010,925 42,889
2006-05-03 22:50 2006-05-03 N-A BOSTON SCIENTIFIC CORP NICHOLAS NICHOLAS J JR Director BUY $21.87 5,000 $109,350 15,000
2006-05-03 16:38 2006-05-02 N-A BOSTON SCIENTIFIC CORP NICHOLAS NICHOLAS J JR Director BUY $22.06 5,000 $110,300 30,000
2006-05-03 22:50 2006-05-03 N-A BOSTON SCIENTIFIC CORP DEPARLE NANCY ANN Director OPT+S $22.00 77,810 $1,711,820 2,553
2006-05-04 03:08 2006-05-01 CYTX PLUS THERAPEUTICS, INC. CALHOUN CHRISTOPHER J Officer OPT+S $8.06 8,200 $66,092 50,000
2006-05-03 19:17 2006-05-01 N-A WEST PHARMACEUTICAL SERVICES INC GAILEY JOHN R Officer OPT+S $36.28 6,000 $217,701 36,328
2006-05-03 19:17 2006-05-01 N-A WEST PHARMACEUTICAL SERVICES INC ABBOTT JOSEPH E Officer OPT+S $36.63 3,000 $109,880 15,760
2006-05-02 21:51 2006-05-01 HAE HAEMONETICS CORP Popovsky Mark A Officer BUY $41.52 258 $10,713 3,042
2006-05-02 21:52 2006-05-01 HAE HAEMONETICS CORP Still William Roche Officer BUY $41.52 311 $12,913 3,669
2006-05-02 21:49 2006-05-01 HAE HAEMONETICS CORP ALLEN PETER M Officer BUY $41.52 310 $12,872 3,112
2006-05-02 21:49 2006-05-01 HAE HAEMONETICS CORP CONCANNON BRIAN Officer BUY $41.52 511 $21,218 7,154
2006-05-02 21:51 2006-05-01 HAE HAEMONETICS CORP LOPEZ ALICIA R Officer BUY $41.52 379 $15,737 59,816
2006-05-02 21:51 2006-05-01 HAE HAEMONETICS CORP RYAN RONALD J Officer BUY $41.52 158 $6,561 1,928
2006-05-02 21:50 2006-05-01 HAE HAEMONETICS CORP EBBELING ROBERT B Officer BUY $41.52 307 $12,747 23,676
2006-05-02 21:51 2006-05-01 HAE HAEMONETICS CORP HANLON SUSAN M Officer BUY $41.52 113 $4,692 594
2006-05-02 22:57 2006-05-02 DXCM DEXCOM INC ST PAUL TRAVELERS COMPANIES INC 10% owner SELL $24.00 2,200,000 $52,800,000 13,838
2006-05-02 19:13 2006-05-02 DXCM DEXCOM INC WARBURG PINCUS PRIVATE EQUITY VIII L P 10% owner SELL $24.00 400,000 $9,600,000 2,295,270
2006-05-02 19:10 2006-05-02 DXCM DEXCOM INC CARNEY SEAN Director SELL $24.00 400,000 $9,600,000 2,295,270
2006-05-02 17:27 2006-05-01 BDX BECTON DICKINSON & CO LUDWIG EDWARD J Director, Officer OPT+S $62.27 19,000 $1,183,130 115,148
2006-05-01 17:52 2006-04-28 DCTH DELCATH SYSTEMS, INC. LADD ROBERT 10% owner BUY $4.47 27,300 $121,963 1,986,291
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.